DCGI Told to Act Against Unapproved Antibiotic FDCs Farhat Nasim14 May 2025 7:48 PM ISTNew Delhi: The Drugs Technical Advisory Board (DTAB), India's apex drug advisory body, has taken a firm stance on curbing the irrational use of...
One FDC Declared Rational, 6 Require Phase IV Data: CDSCO Issues Fresh Guidelines Susmita Roy21 April 2025 6:00 PM ISTNew Delhi: The Central Drugs Standard Control Organisation (CDSCO), under the Ministry of Health and Family Welfare, has issued a detailed directive...
4 Diabetes Medication FDCs including Glimipride Metformin Strength banned by Health Ministry Farhat Nasim18 April 2025 6:13 PM ISTDelhi: The Central Drugs Standard Control Organization (CDSCO) has banned the manufacture, sale, and distribution of certain widely used strengths of...
Govt Bans 35 Combination Drugs, See Full List Farhat Nasim16 April 2025 8:36 PM ISTNew Delhi: The Central Drugs Standard Control Organisation (CDSCO) has issued a stern directive to all State and Union Territory Drug...
Decades Old FDCs Under Review: DCGI Demands Proof of Efficacy Farhat Nasim28 Feb 2025 5:07 PM ISTCDSCO has given manufacturers a final 3-month deadline to submit required data or face regulatory action, including license cancellation.
CDSCO Moves Clinical Trial Site Addition, PI Change Applications to Online Platform Farhat Nasim2 Jan 2025 2:08 PM ISTNew Delhi: The Central Drugs Standard Control Organization (CDSCO), under the Directorate General of Health Services, has announced a streamlined...
34 more multivitamins under Govt scanner after recent ban on 156 drugs Ruchika Sharma26 Aug 2024 4:11 PM ISTNew Delhi: The Government of India is considering a ban on 34 additional multivitamins, following its recent ban on 156 drugs. The said multivitamins...
Glipizide-Metformin, Glimepiride-Metformin-Pioglitazone FDCs Reduce Medication Costs in Indian T2DM: Study Dr. Kamal Kant Kohli27 May 2024 11:30 AM ISTAffordable combination medicines, such as glipizide + metformin and glimepiride + metformin + pioglitazone offer considerable advantages and can...
Glenmark Pharma launches Sitagliptin and its FDCs for Type 2 diabetes in India Ruchika Sharma7 July 2022 3:28 PM ISTThe medicines will be available under the brand name SITAZIT, SITAZIT- M, SITAZIT- M ER and SITAZIT D.
CSDCO calls meeting of makers of 19 older FDCs to examine their rationality Dr. Divya Colin18 Jan 2022 4:45 PM ISTNew Delhi: With an aim to understand the rationality of certain older Fixed Dose Combination (FDC) molecules in the market, The Central Drug Standard...
Examine 16 irrational FDCs for further submission: Health Ministry to DTAB constituted sub-committee Medical Dialogues Team5 May 2021 5:21 PM ISTNew Delhi: The Drugs Technical Advisory Board (DTAB) constituted sub-committee has been directed by the Union Health Ministry to examine 16 irrational...
Citing voglibose, sitagliptin incompatibility, CDSCO panel rejects Hetero Labs proposal for antidiabetic FDC drug Medical Dialogues Team13 March 2021 6:50 PM ISTNew Delhi: In a setback to Hetero Labs, the Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization (CDSCO)...
